Literature DB >> 7875451

[Pericarditis during inflammatory bowel diseases. Extra-intestinal or iatrogenic complication?].

D Heresbach1, A Rabot, N Génetet, P Marteau, C Stéphan, J F Bretagne, M Gosselin.   

Abstract

Acute pericarditis is rarely associated with inflammatory bowel disease. In such cases, when usual aetiologies have been excluded, pericarditis can be considered to be either an extraintestinal manifestation of inflammatory bowel disease or due to an adverse drug effect. We report a case of acute pericarditis in a 17-year old patient with ulcerative colitis treated with mesalazine for 15 days. Mesalazine was discontinued with a prompt and spontaneous resolution of the symptoms. Extensive investigations revealed no known cause for his pericarditis. Eight days and 75 days after the diagnosis, a lymphoblastic transformation test in the presence of mesalazine was performed and was positive for concentration greater than or equal to 10 micrograms/mL; this test was negative in 3 control patients treated with mesalazine without adverse drug effect. This observation together with the rare documented cases allows to consider the possibility that pericarditis may be caused by an adverse drug reaction in these patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7875451

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  2 in total

Review 1.  5-Aminosalicylic Acid-Associated Myocarditis and Pericarditis: A Narrative Review.

Authors:  Glen Brown
Journal:  Can J Hosp Pharm       Date:  2016-12-23

Review 2.  A Review of Extraintestinal Manifestations & Medication-Induced Myocarditis and Pericarditis in Pediatric Inflammatory Bowel Disease.

Authors:  Kevin Cesa; Catherine Cunningham; Tyler Harris; Whitney Sunseri
Journal:  Cureus       Date:  2022-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.